powered by GuideStar

Family Health International

Also Known As: FHI

PO Box 13950
Research Triangle Park, NC 27709

www.fhi.org

Mission and Programs

Mission

FHI improves lives worldwide through the synergistic strengths of research and programs in public health.

Programs

Family Health International (FHI) is dedicated to improving lives, knowledge, and understanding worldwide through a highly diversified program of research, education, and services in family health and HIV/AIDS prevention and care. Since its inception in 1971, FHI has formed partnerships with national governments, local communities and the private sector in countries throughout the developing world to support lasting improvements in the health of individuals and the effectiveness of entire health systems. FHI's corporate headquarters are located in Research Triangle Park North Carolina, and the Public Health Programs (formerly the Institute for HIV/AIDS) is based in the Washington, D.C. metro area. The ethnically diverse staff includes more than 2100 professionals located in 70 countries. FHI is one of the world's most successful non-governmental organizations (NGOs), managing programs and conducting applied research in global health, most prominently in HIV/AIDS, reproductive health and family planning. Based in the US, FHI conducts ongoing projects in more than 65 countries and maintains offices in 35 countries. For more than three decades, FHI has worked closely with US and international partners to improve lives, knowledge, and understanding worldwide through research, education and services. In addition to family planning and reproductive health, HIV/AIDS prevention, care and treatment, FHI has expanded its technical assistance, program implementation and research portfolio to include infectious diseases, specifically tuberculosis (TB), malaria, and avian influenza. FHI's funding partners include the United Kingdom's Department for International Development (DFID), the Bill & Melinda Gates Foundation, Bristol-Myers Squibb, the United States Agency for International Development (USAID) and various governments and foundations. FHI's staff includes over 2100 public health specialists, business professionals, communications experts, economists, doctors, nurses, program managers, social scientists, and trainers. Underlying all of FHI's work is a commitment to build local capacity and promote sustainable systems to deliver high quality family planning and reproductive health services, as well as HIV/AIDS prevention, testing, care and treatment services.

Who We Are

FHI advances global development by supporting health and offering hope worldwide.

NTEE Code

Goals and Results


Accomplishments for Fiscal Year Ending September 30, 2008

  1. Reached 6.4 million people through community AIDS outreach programs.
  2. Assisted close to 200,000 children orphaned or made vulnerable by AIDS.
  3. Provided antiretroviral therapy to more than 90,000 people in Africa, Asia and Latin America.

Objectives for Fiscal Year Beginning October 1, 2008

  1. Increase the number of people receiving antiretroviral treatment for HIV in the developing world.
  2. Increase the number of children under age 15 receiving antiretroviral treatment for HIV by 15-20 percent in the developing world.
  3. Increase access to safe and effective contraception in the developing world.

Chief Executive Profile

Albert J. Siemens, PhD, is Chairman and Chief Executive Officer of Family Health International (FHI)headquartered in Research Triangle Park, NC. His organizational leadership assures top quality performance in FHI's health research and service programs while guiding the development of the company. He joined FHI in 1983 as Director of Clinical Trials to lead multinational contraceptive clinical research. Three years later, as FHI's Vice President of Research, he co-founded Clinical Research International (CRI), an affiliate of FHI that provided clinical research services to pharmaceutical companies. He was President of CRI until the company was acquired by ClinTrials Research in 1990. Following seven years as Executive Vice President of ClinTrials Research, he rejoined FHI as CEO and was appointed Chairman in 2006. Since 1999, he has also been Chairman and Chief Executive Officer of PharmaLinkFHI, Inc., an affiliate that provides internet-based clinical research services. Prior to joining FHI, Dr. Siemens oversaw clinical studies of cardiovascular, antibiotic, anti-inflammatory and psychotropic agents in domestic andinternational divisions of Pfizer Inc. His clinical research and organizational leadership background is augmented by research management and teaching experience at the Research Institute on Alcoholism and the State University of New York at Buffalo. Dr. Siemens holds BSc and MSc degrees from the University of Manitoba, and a PhD in pharmacology from the University of Toronto.

Financial Data

Revenues and Expenses: Fiscal Year Ending September 30, 2008

Revenue
Contributions $54,340,859
Government Grants $302,347,393
Program Services $12,549,852
Investments $637,480
Special Events $0
Sales $0
Other $0
Total Revenue $369,875,584
Expenses
Program Services $322,289,768
Administration $44,080,118
Other $185,852
Total Expenditures $366,555,738
Net Gain/Loss $3,319,846

Balance Sheet: Fiscal Year Ending September 30, 2008

Note: The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot long survive, but the types of assets and liabilities also must be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

  October 1, 2007 September 30, 2008 Change
Assets      
Cash & Equivalent $25,801,431 $29,488,335 $3,686,904
Accounts Receivable $16,493,799 $17,105,906 $612,107
Pledges & Grants Receivable $0 $0 $0
Receivables/Other $0 $0 $0
Inventories for Sale or Use $0 $0 $0
Investments/Securities $0 $0 $0
Investments/Other $0 $0 $0
Fixed Assets $1,977,685 $2,029,045 $51,360
Other $15,578,460 $16,353,210 $774,750
Total Assets $59,851,375 $64,976,496 $5,125,121
Liabilities      
Accounts Payable $17,525,664 $21,360,480 $3,834,816
Grants Payable $0 $0 $0
Deferred Revenue $16,462,016 $13,267,584 ($3,194,432)
Loans and Notes $0 $73,398 $73,398
Tax-Exempt Bond Liabilities $0 $0 $0
Other $13,495,513 $14,587,006 $1,091,493
Total Liabilities $47,483,193 $49,288,468 $1,805,275
Fund Balance $12,368,182 $15,688,028 $3,319,846

Basic Information